These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 1591725
21. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells. Sako T, Yuspa SH, Herald CL, Pettit GR, Blumberg PM. Cancer Res; 1987 Oct 15; 47(20):5445-50. PubMed ID: 2888531 [Abstract] [Full Text] [Related]
22. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. Jalava A, Akerman K, Heikkilä J. J Cell Physiol; 1993 May 15; 155(2):301-12. PubMed ID: 8482723 [Abstract] [Full Text] [Related]
23. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells. Wang Z, Su ZZ, Fisher PB, Wang S, VanTuyle G, Grant S. Exp Cell Res; 1998 Oct 10; 244(1):105-16. PubMed ID: 9770354 [Abstract] [Full Text] [Related]
24. Inhibition of PMA-induced human T cell proliferation by bryostatin is associated with enhanced degradation of conventional protein kinase C (cPKC): Ca2+ signals restore mitogenic activity without abrogating enhanced cPKC degradation. Galron D, Tamir A, Altman A, Isakov N. Cell Immunol; 1994 Oct 01; 158(1):195-207. PubMed ID: 8087865 [Abstract] [Full Text] [Related]
25. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60). Kraft AS, Baker VV, May WS. Oncogene; 1987 May 01; 1(2):111-8. PubMed ID: 3325877 [Abstract] [Full Text] [Related]
26. Protein kinase C-alpha but not protein kinase C-epsilon is differentially down-regulated by bryostatin 1 and tetradecanoyl phorbol 13-acetate in SH-SY5Y human neuroblastoma cells. Jalava A, Lintunen M, Heikkilä J. Biochem Biophys Res Commun; 1993 Mar 15; 191(2):472-8. PubMed ID: 8461005 [Abstract] [Full Text] [Related]
32. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1. Lorenzo PS, Bögi K, Hughes KM, Beheshti M, Bhattacharyya D, Garfield SH, Pettit GR, Blumberg PM. Cancer Res; 1999 Dec 15; 59(24):6137-44. PubMed ID: 10626804 [Abstract] [Full Text] [Related]
33. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. Szallasi Z, Smith CB, Pettit GR, Blumberg PM. J Biol Chem; 1994 Jan 21; 269(3):2118-24. PubMed ID: 8294465 [Abstract] [Full Text] [Related]
34. Successful treatment of murine melanoma with bryostatin 1. Schuchter LM, Esa AH, May S, Laulis MK, Pettit GR, Hess AD. Cancer Res; 1991 Jan 15; 51(2):682-7. PubMed ID: 1985785 [Abstract] [Full Text] [Related]
35. Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells. Dell'Aquila ML, Herald CL, Kamano Y, Pettit GR, Blumberg PM. Cancer Res; 1988 Jul 01; 48(13):3702-8. PubMed ID: 3132318 [Abstract] [Full Text] [Related]
37. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha. Clarke H, Ginanni N, Laughlin KV, Smith JB, Pettit GR, Mullin JM. Exp Cell Res; 2000 Nov 25; 261(1):239-49. PubMed ID: 11082294 [Abstract] [Full Text] [Related]